Differential effects of protein kinase A on Ras effector pathways

Molecular and Cellular Biology

Volumn 18, Issue 7, 1998, Pages 3718-3726

  Miller, Marsha J ^a   Rioux, Lise ^a   Prendergast, Gregory V ^a   Cannon, Sarah ^b   White, Michael A ^c   Meinkoth, Judy L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ARTICLE; CELL PROLIFERATION; DNA SYNTHESIS INHIBITION; EFFECTOR CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; EPITHELIUM CELL; GROWTH INHIBITION; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; PROTEIN FAMILY; RAT; RECEPTOR DOWN REGULATION;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0031835656     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.18.7.3718     Document Type: Article

References (66)

1. Al-Alawi, N., D. W. Rose, C. Buckmaster, N. Ahn, U. Rapp, J. Meinkoth, and J. R. Feramisco. 1995. Thyrotropin-induced mitogenesis is Ras dependent but appears to bypass the Raf-dependent cytoplasmic kinase cascade. Mol. Cell. Biol. 15:1162-1168.
2. Albright, C. F., B. W. Giddings, J. Liu, M. Vito, and R. A. Weinberg. ,1993. Characterization of a guanine nucleotide dissociation stimulator for a ras-related GTPase. EMBO J. 12:339-347.
3. Altschuler, D. L., S. N. Peterson, M. C. Ostrowski, and E. G. Lapetina. 1995. Cyclic AMP-dependent activation of Rap1b. J. Biol. Chem. 270:10373-10376.
4. Avvedimento, V. E., A. Musti, A. Fusco, M. J. Bonapace, and R. D. Lauro. 1988. Neoplastic transformation inactivates specific trans-acting factors(s) required for the expression of the thyroglobulin gene. Proc. Natl. Acad. Sci. USA 85:1744-1748.
5. Brandi, M. L., C. M. Rotella, C. Mavilia, F. Franceschelli, A. Tanini, and R. Toccafondi. 1987. Insulin stimulates cell growth of a new strain of differentiated rat thyroid cells. Mol. Cell. Endocrinol. 54:91-103.
6. Burgering, B. M. T., and J. L. Bos. 1995. Regulation of Ras-mediated signalling: more than one way to skin a cat. Trends Biochem. Sci. 20:18-22.
7. Burns, J. S., J. P. Blaydes, P. A. Wright, L. Lemoine, J. A. Bond, E. D. Williams, and D. Wynford-Thomas. 1992. Stepwise transformation of primary thyroid epithelial cells by a mutant Ha-ras oncogene: an in vitro model of tumor progression. Mol. Carcinog. 6:129-139.
8. Cantor, S. B., T. Urano, and L. A. Feig. 1995. Identification and characterization of Ral-binding protein 1, a potential downstream target of Ral GT-Pases. Mol. Cell. Biol. 15:4578-4584.
9. Carrasco, N. 1993. Iodide transport in the thyroid gland. Biochim. Biophys. Acta 1154:65-82.
10. 9a.Cass, L. A., J. L. Meinkoth. 1998. Differential effects of cyclic adenosine 3′, 5′-monophosphate or p70 ribosomal S6 kinase. Endocrinology 139:1991-1998.
11. Cook, S. J., and F. McCormick. 1993. Inhibition by cAMP of Ras-dependent activation of Raf. Science 262:1059-1062.
12. Dumont, J. E., F. Lamy, P. Roger, and C. Maenhaut. 1992. Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors. Physiol. Rev. 72:667-697.
13. Feramisco, J. R., M. Gross, T. Kamata, M. Rosenberg, and R. W. Sweet. 1984. Microinjection of the oncogene form of the human H-ras (T-24) protein results in rapid proliferation of quiescent cells. Cell 38:109-117.
14. Frodin, M., P. Peraldi, and E. V. Obberghen. 1994. Cyclic AMP activates the mitogen-activated protein kinase cascade in PC12 cells. J. Biol. Chem. 269: 6207-6214.
15. Frost, J. A., H. Steen, P. Shapiro, T. Lewis, N. Ahn, P. E. Shaw, and M. H. Cobb. 1997. Cross-cascade activation of ERKs and ternary complex factors by Rho family proteins. EMBO J. 16:6426-6438.
16. Fusco, A., M. T. Berlingieri, P. P. Di Fiore, G. Portella, M. Grieco, and G. Vecchio. 1987. One-and two-step transformations of rat thyroid epithelial cells by retroviral oncogenes. Mol. Cell. Biol. 7:3365-3370.
17. Grammer, T. C., and J. Blenis. 1997. Evidence for MEK-tndependent pathways regulating the prolonged activation of the ERK-MAP kinases. Oncogene 14:1635-1642.
18. Häfner, S., H. S. Adler, H. Mischak, P. Janosch, G. Heidecker, A. Wolfman, S. Pippig, M. Lohse, M. Ueffing, and W. Kolch. 1994. Mechanism of inhibition of Raf-1 by protein kinase A. Mol. Cell. Biol. 14:6696-6703.
19. Herrmann, C., G. Horn, M. Spaargaren, and A. Wittinghofer. 1996. Differential interaction of the Ras family GTP-binding proteins H-Ras, Rap1A, and R-Ras with the putative effector molecules Raf kinase and Ral-guanine nucleotide exchange factor. J. Biol. Chem. 271:6794-6800.
20. Heuverswyn, B. V., C. Steydio, H. Brocas, S. Refetoff, J. Dumont, and G. Vassart. 1984. Thyrotropin controls transcription of the thyroglobulin gene. Proc. Natl. Acad. Sci. USA 81:5941-5945.
21. Hofer, F., S. Fields, C. Schneider, and G. S. Martin. 1994. Activated Ras interacts with the Ral guanine nucleotide dissociation stimulator. Proc. Natl. Acad. Sci. USA 91:11089-11093.
22. Ikeda, M., S. Koyama, M. Okazaki, K. Dohi, and A. Kikuchi. 1995. rap1 p21 regulates the interaction of ras p21 with RGL, a new effector protein of ras p21. FEBS Lett. 375:37-40.
23. Jiang, H., J.-Q. Luo, T. Urano, P. Frankel, Z. Lu, D. A. Foster, and L. A. Feig. 1995. Involvement of Ral GTPase in v-Src-induced phospholipase D activation. Nature 378:409-412.
24. Joneson, T., M. A. White, M. H. Wigler, and D. Bar-Sagi. 1996. Stimulation of membrane ruffling and MAP kinase activation by distinct effectors of RAS. Science 271:810-812.
25. Julien-Flores, V., O. Dorseuil, F. Romero, F. Letourneur, S. Saragosti, R. Berger, A. Tavitian, G. Gacon, and J. H. Camonis. 1995. Bridging Ral GTPase to Rho pathways. J. Biol. Chem. 270:22473-22477.
26. Kauffmann-Zeh, A., P. Rodriguez-Viciana, E. Ulruch, C. Gilbert, P. Coffer, J. Downward, and G. Evan. 1997. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature 385:544-548.
27. Khosravi-Far, R., P. A. Solski, C. J. Clark, M. S. Kinch, and C. J. Der. 1995. Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation. Mol. Cell. Biol. 15:6443-6453.
28. Khosravi-Far, R., M. A. White, J. K. Westwick, P. A. Solski, M. Chrzanowska-Wodnicka, L. V. Aelst, M. H. Wigler, and C. J. Der. 1996. Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation. Mol. Cell. Biol. 16: 3923-3933.
29. Kikuchi, A., S. D. Demo, Z.-H. Ye, Y.-W. Chen, and L. T. Williams. 1994. ralGDS family members interact with the effector loop of ras p21. Mol. Cell. Biol. 14:7483-7491.
30. Kikuchi, A., and L. T. Williams. 1996. Regulation of interaction of rasp21 with RalGDS and Raf-1 by cyclic AMP-dependent protein kinase. J. Biol. Chem. 271:588-594.
31. Kitayama, H., Y. Sugimoto, T. Matsuzaki, Y. Ikawa, and M. Noda. 1989. A ras-related gene with transformation suppressor activity. Cell 56:77-84.
32. Kohn, L. D., H. Shimura, Y. Shimura, A. Hidaka, C. Giuliani, G. Napolitano, M. Ohmori, G. Laglia, and M. Saji. 1995. The thyrotropin receptor. Vitam. Horm. 50:287-385.
33. Kupperman, E., W. Wen, and J. L. Meinkoth. 1993. Inhibition of thyrotropin-stimulated DNA synthesis by mieroinjection of inhibitors of cellular Ras and cyclic AMP-dependent protein kinase. Mol. Cell. Biol. 13:4477-4484.
34. Kupperman, E., D. Wofford, W. Wen, and J. L. Meinkoth. 1996. Ras inhibits thyroglobulin expression but not cyclic adenosine monophosphate-mediated signaling in Wistar rat thyrocytes. Endocrinology 137:96-104.
35. LaMorte, V., A. Goldsmith, J. Spiegel, J. Meinkoth, and J. Feramisco. 1992. Inhibition of DNA synthesis in living cells by microinjection of Gi2 antibodies. J. Biol. Chem. 267:691-694.
36. Lamy, F., F. Wilkin, M. Baptist, J. Posada, P. P. Roger, and J. E. Dumont. 1993. Phosphorylation of mitogen-activated protein kinases is involved in the epidermal growth factor and phorbol ester, but not in the thyrotropin/cAMP, thyroid mitogenic pathway. J. Biol. Chem. 268:8398-8401.
37. Lemoine, N. R., S. Staddon, J. Bond, F. S. Wyllie, J. J. Shaw, and D. Wynford-Thomas. 1990. Partial transformation of human thyroid epithelial cells by mutant Ha-ras oncogene. Oncogene 5:1833-1837.
38. Magnusson, R. P., and B. Rapoport. 1985. Modulation of differentiated function in cultured thyroid cells: thyrotropin control of thyroid peroxidase activity. Endocrinology 116:1493-1500.
39. Marshall, M. S. 1995. Ras target proteins in eukaryotic cells. FASEB J. 9:1311-1318.
40. Meinkoth, J. L., J. D. Cruz, and G. N. Burrow. 1991. TSH, IGF-1 and activated ras protein induce DNA synthesis in cultured thyroid cells. Thyroidology 3:97-102.
41. Miller, M. J., S. Prigent, E. Kupperman, L. Rioux, S.-H. Park, J. R. Feramisco, M. A. White, J. L. Rutkowski, and J. L. Meinkoth. 1997. RalGDS functions in Ras-and cAMP-mediated growth stimulation. J. Biol. Chem. 272:5600-5605.
42. Oldham, S. M., G. J. Clark, L. M. Gangarosa, and J. R. Coffey, Jr. 1996. Activation of the Raf-1/MAP kinase cascade is not sufficient for Ras transformation of RIE-1 epithelial cells. Proc. Natl. Acad. Sci. USA 93:6924-6928.
43. Park, S.-H., and R. A. Weinberg. 1995. A putative effector of Ral has homology to Rho/Rac GTPase activating proteins. Oncogene 11:2349-2355.
44. Peterson, S. N., L. Trabalzini, T. R. Brtva, T. Fischer, D. L. Altschuler, P. Martelli, E. G. Lapetina, C. J. Der, and G. C. White II. 1996. Identification of a novel RalGDS-related protein as a candidate effector for Ras and Rap1. J. Biol. Chem. 271:29903-29908.
45. Prendergast, G. C., R. Khosravi-Far, P. A. Solski, H. Kurzawa, P. F. Lebowitz, and C. J. Der. 1995. Critical role of Rho in cell transformation by oncogenic Ras. Oncogene 10:2289-2296.
46. Qiu, R.-G., J. Chen, D. Kirn, F. McCormick, and M. Symons. 1995. An essential role for Rac in Ras transformation. Nature 374:457-459.
47. Ramocki, M. B., S. E. Johnson, M. A. White, C. L. Ashendel, S. F. Konieczny, and E. J. Taparowsky. 1997. Signaling through mitogen-activated protein kinase and Rac/Rho does not duplicate the effects of activated Ras on skeletal myogenesis. Mol. Cell. Biol. 17:3547-3555.
48. Rioux, L. Unpublished data.
49. Rodriguez-Viciana, P., P. H. Warne, R. Dhand, B. Vanhaesebroeck, I. Gout, M. J. Fry, M. D. Waterfield, and J. Downward. 1994. Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature 370:527-530.
50. Rodrignez-Viciana, P., P. H. Warne, A. Khwaja, B. M. Marte, D. Pappin, P. Das, M. D. Waterfield, A. Ridley, and J. Downward. 1997. Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell 89:457-467.
51. Scheele, J. S., J. M. Rhee, and G. R. Boss. 1995. Determination of the absolute amounts of GDP and GTP bound to Ras in mammalian cells: comparison of parental and Ras-overproducing NIH3T3 fibroblasts. Proc. Natl. Acad. Sci. USA 92:1097-1100.
52. Self, A. J., and A. Hall. 1995. Purification of recombinant Rho/Rac/G25K from Escherichia coli. Methods Enzymol. 256:3-10.
53. Spaargaren, M., and J. R. Bischoff. 1994. Identification of the guanine nucleotide dissociation stimulator for Ral as a putative effector molecule of R-ras, H-ras, and Rap. Proc. Natl. Acad. Sci. USA 91:12609-12613.
54. Stang, S., D. Bottorff, and J. C. Stone. 1997. Interaction of activated Ras with Raf-1 alone may be sufficient for transformation of rat2 cells. Mol. Cell. Biol. 17:3047-3055.
55. Szeberenyi, J., P. Erhardt, H. Cai, and G. M. Cooper. 1992. Role of Ras in signal transduction from the nerve growth factor receptor: relationship to protein kinase C, calcium and cyclic AMP. Oncogene 7:2105-2113.
56. Tang, Y., Z. Chen, D. Ambrose, J. Liu, J. B. Gibbs, J. Chernoff, and J. Field. 1997. Kinase-deficient Pak1 mutants inhibit Ras transformation of Rat-1 fibroblasts. Mol. Cell. Biol. 17:4454-4464.
57. Urano, T., R. Emkey, and L. A. Feig. 1996. Ral-GTPases mediate a distinct downstream signaling pathway from Ras that facilitates cellular transformation. EMBO J. 15:810-816.
58. Vaillancourt, R. R., A. M. Gardner, and G. L. Johnson. 1994. B-Raf-dependent regulation of the MEK-1/mitogen-activated protein kinase pathway in PC12 cells and regulation by cyclic AMP. Mol. Cell. Biol. 14:6522-6530.
59. Vassart, G., and J. E. Damont. 1992. The thyrotropin receptor and the regulation of thyrocyte function and growth. Endocr. Rev. 13:596-611.
60. Vossler, M. R., H. Yao, R. D. York, M.-G. Pan, C. S. Rim, and P. J. Stork. 1997. cAMP activates MAP kinase and elk-1 through a B-Raf-and Rap1-dependent pathway. Cell 89:73-82.
61. White M. A., C. Nicolette, A. Minden, A. Polverino, L. V. Aelst, M. Karin, and M. H. Wigler. 1995. Multiple Ras functions can contribute to mammalian cell transformation. Cell 80:533-541.
62. White, M. A., T. Vale, J. H. Camonis, E. Schaefer, and M. H. Wigler. 1996. A role for RalGDS in mediating Ras-induced transformation. J. Biol. Chem. 271:16439-16442.
63. Wolthuis, R. M. W., B. Bauer, L. J. van't Veer, A. M. M. de Vries-Smits, R. H. Cool, M. Spaargaren, A. Wittinghofer, B. M. Burgering, and J. L. Bos. 1996. RalGDS-like factor (Rlf) is a novel Ras and Rap1A-associating protein. Oncogene 13:353-362.
64. Wu, J., P. Dent, T. Jelinek, A. Wolfman, M. J. Weber, and T. A. Sturgill. 1993. Inhibition of EGF-activated MAP kinase signaling pathway by adenosine 3′5′-monophosphate. Science 262:1065-1068.
65. Xia, Z., M. Dickens, J. Raingeaud, R. J. Davis, and M. E. Greenberg. 1995. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326-1331.
66. Yoshida, Y., M. Kawata, Y. Miura, T. Musha, T. Sasaki, A. Kikuchi, and Y. Takai. 1992. Microinjection of smg/rap1/Krev-1 p21 into Swiss 3T3 cells induces DNA synthesis and morphological changes. Mol. Cell. Biol. 12:3407-3414.